€
4. 98
+0.08
+1.6327%
€
12.85M Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
€ 4.9
Previous Close Want to track 61R and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Laboratoires Euromedis S.A. (61R) Statistics
Valuation metrics
Market Cap 12.85M
Enterprise value -
Trailing P/E (ttm) -2.33
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) -
Enterprise Value/Revenue -
Enterprise Value/EBITDA -
Overview
Shares outstanding 2.85M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 38
Average volume (90 days) 19
Price summary
52-Week low 3.73
52-Week high 5.55
Beta -
50-Day moving average 4.74
200-Day moving average 4.2
Financials
Fiscal year
Fiscal year ends 31 Dec 2024
Most recent quarter (mrq) 31 Dec 2024
Profitability
Profit margin 0.05%
Operating margin 0.02%
Operational effectiveness
Return on assets -0.16%
Return on equity -0.37%
Income Statement
Revenue (ttm) 36.22M
Revenue per share (ttm) 12.69
Quarterly revenue growth (yoy) -
Gross profit (ttm) 1.93M
EBITDA 1.96M
Net income to common (ttm) -6.11M
Diluted EPS (ttm) -2.14
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 15.18M
Total cash per share (mrq) -
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 3.53%
Book value per share (mrq) -
Cash Flow
Cash flow statement -5.94M
Levered free cash flow (LFCF) -6.11M
